Importantly, we show that NEK2 depletion impairs cervical cancer progression and radioresistance in a Wnt1-dependent manner, indicating that NEK2 may be a promising target for cervical cancer radiotherapy. This evidence concerns the gene NEK2 and cervical carcinoma.